Latest filing published 04 Jan 2018 for Cardiff Oncology, Inc..
Insider track record
No signal scores available.
Paul Billings: trading record in brief
Paul Billings appears in our data through filings on Cardiff Oncology, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 2 September 2017 to 2 January 2018.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 4 January 2018 came the latest disclosure, an option exercise in Cardiff Oncology, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul Billings
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 16,667 shares0Common StockSEC:0000899243-18-000484:0
- 16,667 shares0Common StockSEC:0000899243-18-000531:0
- 6,498 shares0Common StockSEC:0001104659-17-055893:0
3 of 3 declarations